Posts Tagged ‘brain tumor’

Interviews with Dr Kedar Prasad (antioxidants and cancer) and Dr Charles Majors (chiropractor and cancer survivor)

Sunday, March 31st, 2013

Dr prasadDR Major

Guest on the Holistic Health Show yesterday were Dr Kedar Prasad (left) and Dr Charles Majors.  Dr Prasad is author of Fighting Cancer with Antioxidants and over 200 papers in peer reviewed journals. He is the director of the Center for Vitamins and Cancer Research at the U of Colorado Health Sciences Center. More information was published previously on this site and can be found at: Http://

Dr Charles Majors has devoted over 15 years studying health and healing to prevent and reverse diseases through natural methods and is the co-author of 2 books. More information was presented earlier on this site and can be found at:

Enjoy the Show below:


Is There a Relationship Between Allergies and Brain Tumors?

Wednesday, August 15th, 2012

New research published online in the Journal of the National Cancer Institute  concluded that there may be a link between allergies and a reduced risk of a serious type of cancer starting in the brain and  known as glioma and the relationship may be stronger among women than men. Researchers have noted this relationship  previously but have  not known whether the reduced risk was a result of the allergies or whether the tumor  preceded the allergies.

Analyzing stored blood samples taken from patients decades before a diagnoses of glioma researchers found that men and women whose blood samples contained allergy-related antibodies had an almost 50 percent lower risk of developing glioma 20 years later than those without signs of allergies. The authors said “The longer before glioma diagnosis that the effect of allergies is present, the less likely it is that the tumor is suppressing allergies. Seeing this association so long before tumor diagnosis suggests our antibodies or some aspect of allergies is reducing tumor risk.”

Results also suggest that women whose blood samples tested positive for specific allergy antibodies had at least a 50 percent lower risk for the most serious  and common type of these brain tumors called glioblastoma but this was not seen in men. However, men who tested positive for both specific antibodies of unknown function had a 20% lower risk of this tumor than men who tested negative.

Blood samples from 594 people diagnosed with glioma (374 of these diagnosed with glioblastoma) between 1974 and 2007 were matched with blood samples by date of sample, age and sex of participant with 1,177 people who were not diagnosed with glioma for comparison and analysis. Further analysis of the samples is planned. More information is available at:

Virus and Bacterial Enzyme Together May Fight Brain Tumor Better

Friday, January 21st, 2011


Research published online in the journal Clinical Cancer Research found that the oncolytic virus that is engineered to destroy cancer cells may work better to treat brain tumors if combined with an enzyme that helps penetrate the tumor. The enzyme, chondroitinase, facilitates movement through the protein molecules that fill space between cells and that impedes the movement of the virus through the tumor.

Testing in animals transplanted with the most deadly form of brain cancer cells, human glioblastoma, ” the enzyme armed virus improved survival by 52 percent compared with controls and in some cases eliminated the tumor entirely.” In the study, researchers injected the deadly brain cancer cells under the skin of eight animals. After tumors developed they treated the tumors with the enzyme-armed virus. These subjects survived an average of 28 days compared to the controls that were treated with the virus only who survived 16 days. Two animals in the research group remained tumor free after 80 days. In a second study where the deadly cancer cells were injected into the brain even better results were found with a 32 to 21 day ratio for survival giving an improvement of 52 percent. Again 2 animals in the research group lived more than 80 days and showed no trace of the tumor. Researchers concluded that “results indicated that an oncolytic virus armed with this enzyme can have a significantly greater anticancer effect compared with a similar virus without the enzyme.”